Assertio Holdings Inc (ASRT)
1.03
+0.02
(+1.98%)
USD |
NASDAQ |
May 03, 16:00
1.025
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Gross Profit (Quarterly): 23.26M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 23.26M |
September 30, 2023 | 28.57M |
June 30, 2023 | 36.22M |
March 31, 2023 | 37.00M |
December 31, 2022 | 44.34M |
September 30, 2022 | 30.20M |
June 30, 2022 | 30.60M |
March 31, 2022 | 32.34M |
December 31, 2021 | 28.43M |
September 30, 2021 | 22.42M |
June 30, 2021 | 21.45M |
March 31, 2021 | 22.87M |
December 31, 2020 | 23.40M |
September 30, 2020 | 28.10M |
June 30, 2020 | 15.38M |
March 31, 2020 | 19.52M |
December 31, 2019 | 56.66M |
September 30, 2019 | 52.90M |
June 30, 2019 | 55.08M |
March 31, 2019 | 55.35M |
December 31, 2018 | 41.90M |
September 30, 2018 | 74.52M |
June 30, 2018 | 60.52M |
March 31, 2018 | 116.36M |
December 31, 2017 | 76.70M |
Date | Value |
---|---|
September 30, 2017 | 78.02M |
June 30, 2017 | 80.73M |
March 31, 2017 | 72.67M |
December 31, 2016 | 101.25M |
September 30, 2016 | 90.28M |
June 30, 2016 | 95.72M |
March 31, 2016 | 81.23M |
December 31, 2015 | 90.16M |
September 30, 2015 | 83.94M |
June 30, 2015 | 71.64M |
March 31, 2015 | 29.09M |
December 31, 2014 | 191.36M |
September 30, 2014 | 47.96M |
June 30, 2014 | 63.06M |
March 31, 2014 | 72.84M |
December 31, 2013 | 38.44M |
September 30, 2013 | 35.71M |
June 30, 2013 | 28.28M |
March 31, 2013 | 24.69M |
December 31, 2012 | 24.27M |
September 30, 2012 | 31.52M |
June 30, 2012 | 12.67M |
March 31, 2012 | 16.32M |
December 31, 2011 | 11.51M |
September 30, 2011 | 15.37M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
15.38M
Minimum
Jun 2020
56.66M
Maximum
Dec 2019
32.04M
Average
28.57M
Median
Sep 2023
Gross Profit (Quarterly) Benchmarks
Ocular Therapeutix Inc | 13.42M |
Cormedix Inc | 0.00 |
Verastem Inc | -- |
Puma Biotechnology Inc | 47.86M |
CytomX Therapeutics Inc | -- |